A neurotechnology company that provides a portable EEG-based platform for objective cognitive assessment.

The Project

With a lean team and a broad market reach, they needed to evolve their sales approach to enable scalable, long-term growth. There was also an opportunity to refine their market strategy by focusing on high-value customer segments. Additionally, their sales model required development to better support consistent product usage and generate recurring revenue. Internally, improving the handoff between sales and customer success teams was essential to streamline workflows and increase overall efficiency.

 

The Solution

Factor 7’s solution focused on refining the company’s go-to-market strategy by concentrating commercial efforts on high-usage neurology clinics with established reimbursement pathways. We streamlined the sales structure by resetting the field team and implementing a hybrid Account Executive/Manager model to drive both acquisition and product usage. To support growth in priority states, we recruited high-potential regional representatives and developed tailored compensation plans. Finally, we enhanced customer success by improving the handoff between sales and onboarding, boosting scan utilization and reducing churn.

The Results

Key outcomes included renewed sales momentum, with a new representative in the Western U.S. actively onboarding and reactivating dormant accounts to revive past opportunities. The company secured its first sales under a new subscription-based model, validating the revised revenue approach. A clear roadmap was also established to strategically scale the direct sales team from two to four representatives in 2025. Additionally, messaging across sales, onboarding, and marketing is now fully aligned around sales and reimbursement, creating a more consistent and effective customer journey.

“Mark and the Factor 7 Medical team brought structure, clarity, and strategic thinking to our commercial organization. They helped us move from gunslinging to grounded execution—without losing momentum.”

Derek Norsworthy
CEO of NeuroCatch

Previous
Previous

EndoEvolve